Technical Analysis for TRLS - TRLSTrellus Health plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 2.86% | |
| Wide Bands | Range Expansion | 2.86% | |
| Doji - Bullish? | Reversal | 2.86% | |
| Outside Day | Range Expansion | 2.86% | |
| Wide Bands | Range Expansion | 2.86% | |
| New 52 Week Closing Low | Bearish | 2.86% | |
| 180 Bearish Setup | Bearish Swing Setup | 2.86% | |
| Volume Surge | Other | 2.86% | |
| Inside Day | Range Contraction | 2.86% | |
| Wide Bands | Range Expansion | 2.86% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 3 hours ago |
| Down 2% | about 3 hours ago |
| Down 1% | about 3 hours ago |
| 1.5x Volume Pace | about 3 hours ago |
| Up 2% | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Specialties Clinical Medicine Autoimmune Diseases Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease Assistive Technology Inflammatory Bowel Diseases Treatment Of Inflammatory Bowel Diseases
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Specialties Clinical Medicine Autoimmune Diseases Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease Assistive Technology Inflammatory Bowel Diseases Treatment Of Inflammatory Bowel Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.65 |
| 52 Week Low | 1.5 |
| Average Volume | 322,188 |
| 200-Day Moving Average | 4.76 |
| 50-Day Moving Average | 3.02 |
| 20-Day Moving Average | 2.19 |
| 10-Day Moving Average | 1.93 |
| Average True Range | 0.36 |
| RSI (14) | 3.85 |
| ADX | 20.87 |
| +DI | 12.29 |
| -DI | 21.56 |
| Chandelier Exit (Long, 3 ATRs) | 1.93 |
| Chandelier Exit (Short, 3 ATRs) | 2.57 |
| Upper Bollinger Bands | 2.84 |
| Lower Bollinger Band | 1.54 |
| Percent B (%b) | 0.16 |
| BandWidth | 59.38 |
| MACD Line | -0.35 |
| MACD Signal Line | -0.36 |
| MACD Histogram | 0.0097 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.04 | ||||
| Resistance 3 (R3) | 2.07 | 2.00 | 1.99 | ||
| Resistance 2 (R2) | 2.00 | 1.93 | 1.99 | 1.97 | |
| Resistance 1 (R1) | 1.88 | 1.88 | 1.85 | 1.85 | 1.96 |
| Pivot Point | 1.81 | 1.81 | 1.80 | 1.80 | 1.81 |
| Support 1 (S1) | 1.69 | 1.74 | 1.66 | 1.66 | 1.54 |
| Support 2 (S2) | 1.62 | 1.69 | 1.61 | 1.53 | |
| Support 3 (S3) | 1.50 | 1.62 | 1.51 | ||
| Support 4 (S4) | 1.47 |
